ロード中...
Managing Antiplatelet Therapy and Anticoagulants in Patients with Coronary Artery Disease and Atrial Fibrillation
Oral anticoagulation (OAC) is essential in patients with atrial fibrillation (AF). Interestingly coronary artery disease coexists in 20–30% of these patients.[1,2] Balancing the risk of bleeding and thromboembolism is very important for the management of patients on OAC, especially than when such pa...
保存先:
| 出版年: | J Atr Fibrillation |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Cardiofront, Inc
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5135189/ https://ncbi.nlm.nih.gov/pubmed/27957230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4022/jafib.1318 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|